ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed
Louis De Palatis
Matched on OpenAlex author ID A5087758752. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2014: 2 papers · 2015: 1 paper
Papers 3
- Current and Future Trends in Early Detection of Pancreatic Cancer: Molecular Targets and PET Probes. First author DOI 10.2174/0929867322666150821094015↗
- Optimization of precursor synthesis, formulation and stability of 1'-[18F]fluoroethyl-β-D-lactose ([18F]FEL) for preclinical studies in detection of pancreatic… First author DOI 10.1016/j.nucmedbio.2014.01.002↗
- Preliminary evaluation of 1'-[(18)F]fluoroethyl-β-D-lactose ([(18)F]FEL) for detection of pancreatic cancer in nude mouse orthotopic xenografts. Co-author DOI 10.1016/j.nucmedbio.2014.08.001↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mian M. Alauddin · 3 shared papers, 2014–2015 · strength 0.22
- Paper Current and Future Trends in Early Detection of Pancreatic Cancer: Molecular Targets and PET Probes. DOI 10.2174/0929867322666150821094015↗
- Paper Optimization of precursor synthesis, formulation and stability of 1'-[18F]fluoroethyl-β-D-lactose ([18F]FEL) for precli… DOI 10.1016/j.nucmedbio.2014.01.002↗
- Paper Preliminary evaluation of 1'-[(18)F]fluoroethyl-β-D-lactose ([(18)F]FEL) for detection of pancreatic cancer in nude mou… DOI 10.1016/j.nucmedbio.2014.08.001↗
- Vincenzo Paolillo · 2 shared papers, 2014 · strength 0.12
- Paper Optimization of precursor synthesis, formulation and stability of 1'-[18F]fluoroethyl-β-D-lactose ([18F]FEL) for precli… DOI 10.1016/j.nucmedbio.2014.01.002↗
- Paper Preliminary evaluation of 1'-[(18)F]fluoroethyl-β-D-lactose ([(18)F]FEL) for detection of pancreatic cancer in nude mou… DOI 10.1016/j.nucmedbio.2014.08.001↗
- Thiruvengadam Arumugam · 1 shared paper, 2014 · strength 0.05
- Craig D. Logsdon · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.